Is Buying 52-Week Stock Like Medifast, Inc. (MED) a Winning Strategy?

May 16, 2018 - By David Engel

Medifast, Inc. (NYSE:MED) Logo

Investors sentiment increased to 1.33 in Q4 2017. Its up 0.33, from 1 in 2017Q3. It increased, as 14 investors sold Medifast, Inc. shares while 56 reduced holdings. 36 funds opened positions while 57 raised stakes. 10.23 million shares or 0.32% more from 10.20 million shares in 2017Q3 were reported.
The Minnesota-based Ameriprise Fincl has invested 0% in Medifast, Inc. (NYSE:MED). Vanguard Group invested in 0% or 712,002 shares. Metropolitan Life Insurance Co New York has 3,392 shares. Rice Hall James & Associates Limited Liability Corporation accumulated 38,770 shares. State Of Alaska Department Of Revenue has 2,098 shares. Numeric Invsts Ltd owns 216,716 shares or 0.11% of their US portfolio. Credit Suisse Ag holds 0% or 11,047 shares. Secor Lp reported 66,143 shares or 0.18% of all its holdings. Aqr Capital Mgmt Lc stated it has 0% in Medifast, Inc. (NYSE:MED). Laurion Mgmt L P has 77,177 shares. Clarivest Asset Mngmt Limited Com stated it has 0.08% of its portfolio in Medifast, Inc. (NYSE:MED). Alps Incorporated has invested 0% in Medifast, Inc. (NYSE:MED). Wells Fargo & Mn holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 71,486 shares. Bridgeway Management accumulated 5,000 shares. The Florida-based State Board Of Administration Of Florida Retirement System has invested 0% in Medifast, Inc. (NYSE:MED).

Since March 8, 2018, it had 0 buys, and 3 sales for $4.87 million activity. MACDONALD MICHAEL C also sold $3.47M worth of Medifast, Inc. (NYSE:MED) on Thursday, March 8.

The stock of Medifast, Inc. (NYSE:MED) hit a new 52-week high and has $138.46 target or 7.00 % above today’s $129.40 share price. The 8 months bullish chart indicates low risk for the $1.56 billion company. The 1-year high was reported on May, 16 by If the $138.46 price target is reached, the company will be worth $109.27 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.50% or $0.65 during the last trading session, reaching $129.4. About 59,003 shares traded. Medifast, Inc. (NYSE:MED) has risen 107.05% since May 16, 2017 and is uptrending. It has outperformed by 95.50% the S&P500.

Analysts await Medifast, Inc. (NYSE:MED) to report earnings on August, 14. They expect $1.00 EPS, up 58.73 % or $0.37 from last year’s $0.63 per share. MED’s profit will be $12.06M for 32.35 P/E if the $1.00 EPS becomes a reality. After $1.01 actual EPS reported by Medifast, Inc. for the previous quarter, Wall Street now forecasts -0.99 % negative EPS growth.

Another recent and important Medifast, Inc. (NYSE:MED) news was published by which published an article titled: “Medifast’s (MED) CEO Dan Chard on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The company has market cap of $1.56 billion. The firm offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, eggs, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home, and Essential 1 brands, as well as Dual Fuel, a sports nutrition pilot program. It has a 56.51 P/E ratio. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.